Grant's research team sought to develop a strategy to prevent the accumulation of MCL-1 in leukemia cells through a clinically effective treatment option. Building upon decades of their earlier ...

The clinical trial experience of combination therapy is limited and the optimal combinations and administration strategies have yet to be clarified.

A combination of two widely available drugs could significantly reduce deaths from heart attacks, a study has found.  New ...

Combination strategies with lenalidomide, bortezomib and dexamethasone seem to have a promising role in maintenance therapies for high-risk patients.

Scientists at VCU Massey Comprehensive Cancer Center have identified an innovative combination of treatment strategies that work collaboratively to effectively kill acute myeloid leukemia (AML ...

Get Instant Summarized Text (Gist) A combination of MCL-1 inhibitors and SRC kinase inhibitors has been found to effectively induce cell death in acute myeloid leukemia (AML) cells. This strategy ...

Scientists have identified an innovative combination of treatment strategies that work collaboratively to effectively kill acute myeloid leukemia (AML) cells, a frequently incurable form of cancer.

New research led by scientists at VCU Massey Comprehensive Cancer Center suggests that a class of drugs known as MCL-1 (myeloid leukemia cell-1) inhibitors interact with a type of kinase inhibitor ...